Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hairun Pharmaceutical is a China-based pharmaceutical company established in 2004, specializing in the research, development, production, and commercialization of chemical drugs. The company maintains a diverse portfolio of finished dosage forms, including tablets, capsules, and granules, with a primary focus on therapeutic areas such as cardiovascular health, anti-infectives, and metabolic disorders. Operating from its GMP-certified manufacturing base in the Jiangning District of Nanjing, Hairun Pharmaceutical produces widely used medications such as Amlodipine Besylate and Azithromycin. The company is committed to providing high-quality, affordable generic medicines while exploring the development of innovative therapeutic solutions for the domestic Chinese market. Its integrated business model encompasses the entire value chain from pharmaceutical R&D to large-scale manufacturing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Hairun Pharmaceutical.